Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Aug 01, 2007 (Vol. 27, No. 14)

TargetP 1.1 Server

  • Useful analyses
  • Nothing significant
There is a world of difference between eukaryotic and prokaryotic cells. The complexity of eukaryotic cells necessitates efficient and practical means of targeting proteins to desired cellular locations. Fortunately, the means by which many of these are targeted is rooted in an amino acid sequence, and this analysis is readily performed by computers. Thus with the appropriate algorithms, one can readily analyze proteins and determine where they will be found in eukaryotic cells. This is particularly helpful in helping to determine the function of unknown genes. To the rescue for this work comes TargetP, which accepts single or multiple sequences (up to 2,000) pasted into a window (FASTA format) and returns information on each protein. It flags proteins targeted for chloroplasts, mitochondria, or for the secretory pathway. The interface is minimal but not a problem.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »